Phibro Animal Health Corporation Class A
PAHCStock
$34.52+10.41%52W
Market Cap$1.37B
P/E28.36x
Div yield1.42%
Beta0.48
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-23.89%
Price vs S&P 500 (4W)5.27%
VGM Score53.49
Market Capitalization$1.37B
P/E Ratio (Annual)28.36x
Indicated Dividend Yield (Annual)1.42%
Earnings Surprise History
Q3 260.76est. 0.73
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
2.44
2.50
2.50
2.50
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PAHCPhibro Animal Health Corporation Class A | C | B | C | $34.52 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Phibro Animal Health Corp provides diversified animal health and mineral nutrition products for food-producing animals including poultry, swine, beef cattle, dairy cattle, and aquaculture. The company manufactures and markets antibacterials, anticoccidials, vaccines, and specialty nutritional products through three segments: Animal Health (its primary revenue driver), Mineral Nutrition, and Performance Products. The company operates in the United States and international markets.